10 Biotech Penny Stocks Redditors Love
The bull market around the biotech sector has cooled in recent weeks as interest rates rise and push investors towards safer havens.
Hoth Therapeutics Inc. (HOTH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.39 | 10,000 | Officer, Director | 828,259 | 2022-09-19 | Filing | |
| $0.40 | 10,000 | Officer, Director | 818,259 | 2022-09-16 | Filing | |
| $199,998.00 | 35,714 | Large Shareholder | 1,735,714 | 2019-02-28 | Filing | |
| $675,000.00 | 1,700,000 | Large Shareholder | 1,700,000 | 2017-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.25 | 400,000 | Large Shareholder | 1,130,674 | 2020-05-26 | Filing | |
| $0.00 | 0 | Other | 0 | 2020-05-26 | Filing | |
| $1.25 | 400,000 | Large Shareholder | 1,130,674 | 2020-05-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 38,804 | $55,878 | 0% | |
| 2. | 23,501 | $33,841 | 0% | |
| 3. | 8,447 | $12,164 | 0% | |
| 4. | 6,337 | $9,125 | 0% | |
| 5. | 1,558 | $2,243 | 0% |
News See All
5 Best Biotech Penny Stocks to Buy Now
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) is a Boston-based biopharma firm founded in 2018. It is placed fifth on our list of 10 best biotech penny stocks to buy now.
Is Hoth Therapeutics, Inc. (HOTH) A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...